Antihypertensive Drug Use and Urinary Albumin Excretion in Non-diabetic Hypertensive Population
نویسندگان
چکیده
Arterial hypertension together with proteinuria is one of the most important factors associated with the progression of both diabetic and nondiabetic chronic kidney disease. Reduction of blood pressure is an efficient way of slowing the progression of this damage whereas antihypertensive drugs vary in their proteinuriaand microalbuminurialowering effects. The objective of the present study was to determine the influence of different antihypertensive drug groups on urinary albumin excretion (UAE) as related to blood pressure in non-diabetic subjects. Subjects (n=39) with chronic renal disease accompanied by mild-to-moderate hypertension and varying degrees of proteinuria were included in the study. Patients were divided into three groups based on UAE values (normoalbuminurics, microalbuminurics and macroalbminurics) and were placed on usual care including nonpharmacological and/or treatment with an antihypertensive drug regime (consisting of one or more out of three different antihypertensive drugs (beta-blocker, ACE inhibitor or calcium-channel blocker) to achieve target blood pressure ≤ 130/85 mmHg. Periodic UAE measurements were performed until regression or significant reduction. A reduction in UAE was observed over time in most patients. However, it reached statistical significance only in the microalbuminuric group (p < 0.01). To further analyze the impact of different antihypertensive drugs on UAE, all patients were stratified into groups depending on the assigned therapy. They were divided into the following 5 groups: 0 – nonpharmacological treatment; 1 – assigned drug group 1; 12 – assigned drug groups 1 and 2; 13 – assigned drug groups 1 and 3; 123 – assigned all 3 drug groups where '1' stood for ACE inhibitors, '2' for beta blockers and '3' for calcium channel blockers. A statistically significant change in mean UAE values at the start and end of the study period in patients assigned to drug groups 12, 13 and 123 was achieved (p<0.05). Also, a statistically significant difference existed in the average reduction of proteinuria under varying antihypertensive drug regimens (p<0.05, ANOVA). Post hoc analyses revealed also a significant difference between groups 0 and 13 (p<0.01, Dunnett T3) as well as groups 1 and 13 (p<0.01, Dunnett T3). In patients with hypertension, changes in UAE depend on the initial UAE values and the type of antihypertensive treatment. ACE inhibitors combined with calcium channel blockers produced higher UAE reduction than other drug groups.
منابع مشابه
Correlates of urinary albumin excretion in young adult blacks and whites: the Coronary Artery Risk Development in Young Adults Study.
The rate of urinary albumin excretion is an important risk factor for kidney failure, stroke, and cardiovascular disease, perhaps because higher albumin excretion reflects endothelial cell dysfunction. The authors characterized urinary albumin excretion according to blood pressure, diabetes mellitus, and other factors in 2,582 Black and White participants in the Coronary Artery Risk Development...
متن کاملComparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.
In these studies, the effect of a 6-wk treatment by placebo, the calcium-channel blocker nifedipine, or the converting-enzyme inhibitor captopril was assessed in normotensive patients with insulin-dependent diabetes and incipient nephropathy. In response to captopril and nifedipine, arterial pressure decreased slightly and to a similar extent. These drugs resulted in opposite effects on urinary...
متن کاملProgression of Incipient Diabetic Nephropathy
The aim of the study was to clarify whether antihypertensive treatment with a selective beta blocker would have an effect on the progression rate of kidney disease in patients with incipient diabetic nephropathy. Six male patients with juvenile-onset diabetes with incipient nephropathy (urinary albumin excretion above 15 /ig/min and total protein excretion below 0.5 g/24 hr) were treated with m...
متن کاملRenal-protective effect of nondepressor dose of cicletanine in diabetic rats with hypertension.
We assessed the renal and cardiac benefits of cicletanine (CIC), a furopyridine derivative drug with diuretic and antihypertensive properties, in diabetic spontaneously hypertensive rats with renal impairment. Uninephrectomized streptozotocin (STZ)-diabetic spontaneously hypertensive Izmo rats (SHRIzm) (10 weeks old) were randomly assigned to receive vehicle or CIC (100 mg/kg/day, orally), and ...
متن کاملModerate Antiproteinuric Effect of Add-On Aldosterone Blockade with Eplerenone in Non-Diabetic Chronic Kidney Disease. A Randomized Cross-Over Study
BACKGROUND Reduction of proteinuria and blood pressure (BP) with blockers of the renin-angiotensin system (RAS) impairs the progression of chronic kidney disease (CKD). The aldosterone antagonist spironolactone has an antiproteinuric effect, but its use is limited by side effects. The present study evaluated the short-term antiproteinuric effect and safety of the selective aldosterone antagonis...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2008